Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease

Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Michel Gowhari, DO, Faiz Ahmed Hussain, MD, Shivi Jain, MD, Laura Kavoliunaite, APN, Robert E. Molokie, MD, Victor R Gordeuk, MD

Blood (2019) 134 (Supplement_1): 3390.

https://doi.org/10.1182/blood-2019-122249

Published: 2019

Journal Articles

Implementation of a Standard Order Set at a Sickle Cell Acute Care Observation Unit

Renee Cheng, MD, Rishi Patel, MD, Sandra Kang, MD, Frances Tian, MD, Xu Zhang, PhD, Jin Han, PharmD, PhD, Jayleen Patel, MD, Netanel Zilberstein, MD, Victor R Gordeuk, MD, Michel Gowhari, DO

Blood (2019) 134 (Supplement_1): 3396.

https://doi.org/10.1182/blood-2019-130877

Published: 2019

Journal Articles

Risk Factors for Kidney Disease in Hb SC and Hb Sβ + -Thalassemia Sickle Cell Disease

Mandella Mensah, Binal N. Shah, Xu Zhang, PhD, Jin Han, PharmD, PhD, Michel Gowhari, DO, Robert E. Molokie, MD, Mark T Gladwin, MD, Victor R Gordeuk, MD, Santosh L. Saraf, MD

Blood (2019) 134 (Supplement_1): 2299.

https://doi.org/10.1182/blood-2019-128668

Published: 2019

Journal Articles

Thrombomodulin and Endothelial Dysfunction in Sickle Cell Anemia

Maria Armila Ruiz, MS, Binal N. Shah, Jin Han, PharmD, PhD, Rasha Raslan, MD, Victor R Gordeuk, MD, Santosh L. Saraf, MD

Blood (2019) 134 (Supplement_1): 3558.

https://doi.org/10.1182/blood-2019-123862

Published: 2019

Journal Articles

Clinical, Laboratory, and Genetic Risk Factors for Thrombosis in Sickle Cell Disease

Andrew Srisuwananukorn, MD, Rasha Raslan, MD, Xu Zhang, PhD, Binal N. Shah, PhD, Jin Han, PharmD, PhD, Michel Gowhari, DO, Shivi Jain, MD, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2018) 132 (Supplement 1): 9.

https://doi.org/10.1182/blood-2018-99-115128

Published: 2018

Journal Articles

Maximum Tolerated Dose Versus Fixed Low-Dose Hydroxyurea for Treatment of Adults with Sickle Cell Anemia - Retrospective Comparison of Two Studies

Titilola S. Akingbola, MBBS, FWACP, Bamidele Tayo, PhD, Chinedu A Ezekekwu, MBBS, Omowunmi Sonubi, MBBS, Santosh L. Saraf, MD, Lewis L. Hsu, Jin Han, PharmD, PhD, Richard S. Cooper, MD, Victor R. Gordeuk, MD

Blood (2018) 132 (Supplement 1): 3656.

https://doi.org/10.1182/blood-2018-99-114990

Published: 2018

Journal Articles

Kidney Ultrasound Findings in Sickle Cell Anemia According to Kidney Disease and the APOL1 G1/G2 Risk Variants

Sandra Kang, MD, Rishi Patel, MD, Ali Kord Valeshabad, MD, Binal N. Shah, PhD, Rishabh Choudhari, Dallas De La Vara, Jin Han, PharmD, PhD, Michel Gowhari, DO, Shivi Jain, MD, Robert E. Molokie, MD, Karen Xie, MD, James P. Lash, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2018) 132 (Supplement 1): 3663.

https://doi.org/10.1182/blood-2018-99-113637

Published: 2018

Journal Articles

Pulmonary Function Abnormalities in Adults with Sickle Cell Anemia

Adam Rock, MD, Binal N. Shah, PhD, Jin Han, PharmD, PhD, Rasha Raslan, MD, Michel Gowhari, DO, Shivi Jain, MD, Xu Zhang, PhD, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2018) 132 (Supplement 1): 3664.

https://doi.org/10.1182/blood-2018-99-114820

Published: 2018

Journal Articles

Type 2 Diabetes Mellitus in Patients with Sickle Cell Disease: A Population-Based Longitudinal Analysis of Three Cohorts

Jifang Zhou, MD, Jin Han, PharmD, PhD, Edith A. Nutescu, PharmD., MS, FCCP, William Galanter, MD PhD MS, Surrey M. Walton, PhD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD, Andrew Srisuwananukorn, MD, Gregory Sampang Calip, PharmD, MPH, PhD

Blood (2018) 132 (Supplement 1): 4817.

https://doi.org/10.1182/blood-2018-99-119039

Published: 2018

Journal Articles

Association of Inpatient Opioid Utilization and Readmission Risk in Sickle Cell Disease

Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Michel Gowhari, DO, Shivi Jain, MD, Robert E. Molokie, MD, Victor R. Gordeuk, MD

Blood (2018) 132 (Supplement 1): 4699.

https://doi.org/10.1182/blood-2018-99-114733

Published: 2018

Journal Articles

Cancer Incidence in Sickle Cell Disease:an Institutional Experience

Shivi Jain, MD, Andrew Srisuwananukorn, MD, Santosh L. Saraf, MD, Xu Zhang, PhD, Jin Han, PharmD, PhD, Michel Gowhari, DO, Robert E. Molokie, MD, Victor R. Gordeuk, MD

Blood (2018) 132 (Supplement 1): 1087.

https://doi.org/10.1182/blood-2018-99-115508

Published: 2018

Journal Articles

Reduced Hemolysis and Related Complications in Females with Sickle Cell Disease

Santosh L. Saraf, MD, Tamir Kanias, PhD, Xu Zhang, PhD, Binal Shah, PhD, Rasha Raslan, MD, Jin Han, PharmD, PhD, Roberto F. Machado, MD, Mark T Gladwin, MD, Victor R. Gordeuk, MD

Blood (2017) 130 (Supplement 1): 3530.

https://doi.org/10.1182/blood.V130.Suppl_1.3530.3530

Published: 2017

Journal Articles

Impact of Delayed Anticoagulant Initiation in Patients with Sickle Cell Disease and Newly Diagnosed Venous Thromboembolism: A Population-Based Cohort Study

Jifang Zhou, MD, Gregory Sampang Calip, PharmD,MPH,PhD, Jin Han, PharmD, PhD, Edith A. Nutescu, PharmD., MS, FCCP

Blood (2017) 130 (Supplement 1): 2139.

https://doi.org/10.1182/blood.V130.Suppl_1.2139.2139

Published: 2017

Journal Articles

Program Expansion of a Day Hospital Dedicated to Manage Sickle Cell Pain

Jin Han, PharmD, PhD, Laura Kavoliunaite, APN, Santosh L. Saraf, MD, Shivi Jain, MD, Johara Hassan, MD, Lewis L Hsu, MD PhD, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Michel Gowhari, DO

Blood (2017) 130 (Supplement 1): 4664.

https://doi.org/10.1182/blood.V130.Suppl_1.4664.4664

Published: 2017

Journal Articles

HMOX1 and Acute Kidney Injury in Sickle Cell Anemia

Santosh L. Saraf, MD, Maya Viner, MD, Ariel Rischall, MD, Binal Shah, PhD, Xu Zhang, PhD, Jin Han, PharmD, PhD, Michel Gowhari, DO, Shivi Jain, MD, Robert E. Molokie, MD, Roberto F. Machado, MD, James P. Lash, MD, Victor R. Gordeuk, MD

Blood (2017) 130 (Supplement 1): 686.

https://doi.org/10.1182/blood.V130.Suppl_1.686.686

Published: 2017

Journal Articles

Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Kidney Function in Patients with Sickle Cell Disease

Jun Choi, MD, Naina Singh, MD, Jin Han, PharmD, PhD, Michel Gowhari, DO, Johara Hassan, MD, Shivi Jain, MD, Robert E Molokie, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2016) 128 (22): 3666.

https://doi.org/10.1182/blood.V128.22.3666.3666

Published: 2016

Journal Articles

Utility of the Revised Cardiac Index Score for Predicting Post-Surgical Outcome in Hb SC or SBeta + -Thalassemia Sickle Cell Disease

Hamid Wardak, Ari Rosenberg, Vladimir Selounski, Michel Gowhari, DO, Robert E. Molokie, MD, Johara Hassan, MD, Jin Han, PharmD, PhD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2015) 126 (23): 3413.

https://doi.org/10.1182/blood.V126.23.3413.3413

Published: 2015

Journal Articles

Chronic Opioid Use Pattern in Adult Patients with Sickle Cell Disease

Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Xu Zhang, PhD, Michel Gowhari, DO, Robert E. Molokie, MD, Johara Hassan, MD, Chaher Alhandalous, MD, Jewel Younge, MA, Taimur Abbasi, MD, Roberto F. Machado, MD, Victor R. Gordeuk, MD

Blood (2015) 126 (23): 3400.

https://doi.org/10.1182/blood.V126.23.3400.3400

Published: 2015

Journal Articles

Age As an Independent Clinical Predictor for Vitamin D Deficiency in Sickle Cell Disease

Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Taimur Abbasi, MD, Xu Zhang, PhD, Robert E. Molokie, MD, Johara Hassan, MD, Michel Gowhari, DO, Chaher Alhandalous, MD, Roberto F. Machado, MD, Victor R. Gordeuk, MD

Blood (2014) 124 (21): 1385.

https://doi.org/10.1182/blood.V124.21.1385.1385

Published: 2014

NARROW

Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease

Implementation of a Standard Order Set at a Sickle Cell Acute Care Observation Unit

Risk Factors for Kidney Disease in Hb SC and Hb Sβ + -Thalassemia Sickle Cell Disease

Thrombomodulin and Endothelial Dysfunction in Sickle Cell Anemia

Clinical, Laboratory, and Genetic Risk Factors for Thrombosis in Sickle Cell Disease

Maximum Tolerated Dose Versus Fixed Low-Dose Hydroxyurea for Treatment of Adults with Sickle Cell Anemia - Retrospective Comparison of Two Studies

Kidney Ultrasound Findings in Sickle Cell Anemia According to Kidney Disease and the APOL1 G1/G2 Risk Variants

Pulmonary Function Abnormalities in Adults with Sickle Cell Anemia

Type 2 Diabetes Mellitus in Patients with Sickle Cell Disease: A Population-Based Longitudinal Analysis of Three Cohorts

Association of Inpatient Opioid Utilization and Readmission Risk in Sickle Cell Disease

Cancer Incidence in Sickle Cell Disease:an Institutional Experience

Reduced Hemolysis and Related Complications in Females with Sickle Cell Disease

Impact of Delayed Anticoagulant Initiation in Patients with Sickle Cell Disease and Newly Diagnosed Venous Thromboembolism: A Population-Based Cohort Study

Program Expansion of a Day Hospital Dedicated to Manage Sickle Cell Pain

HMOX1 and Acute Kidney Injury in Sickle Cell Anemia

Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Kidney Function in Patients with Sickle Cell Disease

Utility of the Revised Cardiac Index Score for Predicting Post-Surgical Outcome in Hb SC or SBeta + -Thalassemia Sickle Cell Disease

Chronic Opioid Use Pattern in Adult Patients with Sickle Cell Disease

Age As an Independent Clinical Predictor for Vitamin D Deficiency in Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only